An Observational Study Called JOIHA to Learn More About How Well the Treatment With Jivi Works to Prevent Problems With Joints in Adults With Hemophilia A.

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 29, 2022

Primary Completion Date

March 31, 2027

Study Completion Date

June 30, 2027

Conditions

Hemophilia AProphylaxis of Bleeding

Interventions

DRUG

Damoctocog alfa pegol (Jivi, BAY94-9027)

Intervention is given as part of routine medical practice.

Trial Locations (1)

Many Locations, Multiple Locations